Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Sanjay P. Bagaria, M.D., uses next-generation sequencing technology to study the tumor and tumor microenvironment of sarcoma, peritoneal surface malignancies and melanoma. The long-term goal of Dr. Bagaria's research is to develop locoregional therapies that can prevent and eradicate these tumors.
Dr. Bagaria's research team has conducted extensive research using preclinical models and advanced genomic sequencing techniques to better identify immune and targeted therapeutics for advanced malignancies.
Advances in genomic sequencing technology now make it possible to integrate genomic data into the clinical practice. However, how best to do this is still unclear. Dr. Bagaria hopes that through his research clinicians can individualize treatment for patients with advanced malignancies based on the genomic characterization of the tumor and tumor microenvironment.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.